Form 8-K - Current report:
SEC Accession No. 0001564590-15-001349
Filing Date
2015-03-05
Accepted
2015-03-05 17:18:06
Documents
2
Period of Report
2015-03-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dvax-8k_20150305.htm 8-K 25884
2 EX-99.1 dvax-ex991_201503056.htm EX-99.1 239456
  Complete submission text file 0001564590-15-001349.txt   266474
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 15678272
SIC: 2834 Pharmaceutical Preparations